RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Narendiran Rajasekaran to Mice

This is a "connection" page, showing publications Narendiran Rajasekaran has written about Mice.
Connection Strength

0.159
  1. Wang X, Kapoor VN, Chin DJ, Klakamp SL, Baruffaldi F, Mohan JF, Haines R, Dulak A, Panduro M, Ren Y, Masia R, Hill JA, LaVallee TM, Rajasekaran N. CHS-114: An Afucosylated Anti-CCR8 Monoclonal Antibody that Selectively Depletes Intratumoral Treg Cells and Induces Antitumor Immune Responses. Mol Cancer Ther. 2026 May 04; 25(5):685-700.
    View in: PubMed
    Score: 0.110
  2. Magdaleno C, Tschumperlin DJ, Rajasekaran N, Varadaraj A. SOCS domain targets ECM assembly in lung fibroblasts and experimental lung fibrosis. Sci Rep. 2024 12 30; 14(1):31855.
    View in: PubMed
    Score: 0.025
  3. Hebb JPO, Mosley AR, Vences-Catal?n F, Rajasekaran N, Ros?n A, Ellmark P, Felsher DW. Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression. Cancer Immunol Immunother. 2018 01; 67(1):47-60.
    View in: PubMed
    Score: 0.015
  4. Rinderknecht CH, Lu N, Crespo O, Truong P, Hou T, Wang N, Rajasekaran N, Mellins ED. I-Ag7 is subject to post-translational chaperoning by CLIP. Int Immunol. 2010 Aug; 22(8):705-16.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support